9 -

9 - Sundstrom S, Bremnes RM, et al. (2002). "Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up." J Clin Oncol 20(24): 4665-72.